![Matthew Calistri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Calistri
Investor Relations Kontakt bei
CEREVEL THERAPEUTICS HOLDINGS, INC.
Profil
Matthew Calistri is currently Senior Director-Investor Relations at Biogen Idec, Inc. (North Carolina), Managing Director at Bain Capital Life Sciences LP since 2024, and Head-Investor Relations at Cerevel Therapeutics Holdings, Inc. Formerly, Mr. Calistri worked as Investor Contact at Biogen, Inc. Education includes an undergraduate degree from Fordham University conferred in 1992 and an MBA from The University of Chicago Booth School of Business conferred in 1999.
Aktive Positionen von Matthew Calistri
| Unternehmen | Position | Beginn |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Investor Relations Kontakt | - |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Investor Relations Kontakt | - |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Investor | 01.09.2024 |
Ehemalige bekannte Positionen von Matthew Calistri
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 01.06.2019 |
Ausbildung von Matthew Calistri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Wählen Sie MarketScreener 
